Fran Curtis: Fighting Bladder Cancer, Inspiring Others
Release Date: 03/05/2025
The Hope Behind Tomorrow's Bladder Cancer Treatments
Bladder Cancer Matters
In this fascinating episode of Bladder Cancer Matters, host Rick Bangs sits down with renowned bladder cancer expert Dr. Robert Svatek to discuss how the field has been transformed over the past 15 years—and where it's headed next. Dr. Svatek reflects on his journey from academic surgeon and researcher to Vice President of Clinical Development at CG Oncology, sharing behind-the-scenes insights into clinical trials, emerging immunotherapies and the collaborative effort required to bring promising new treatments from the laboratory to patients. Whether you're a patient, caregiver, advocate or...
info_outline
The Urinary Diversion Questions Women Are Afraid to Ask
Bladder Cancer Matters
Whether you're facing or supporting someone who is, choosing the can feel overwhelming. In this episode, urologic oncologist Dr. Christine Ibilibor separates fact from fiction, explains the pros and cons of the different diversion options and addresses the unique concerns women often face, from body image and intimacy to recovery and quality of life. Packed with practical advice and reassuring insights, this conversation will help patients feel more informed and more confident when making one of the most important decisions in bladder cancer care.
info_outline
Your Urinary Diversion Decision Made Easier
Bladder Cancer Matters
If you're facing , choosing a urinary diversion may be one of the most important decisions you'll ever make—and one of the hardest to understand. In this episode, reconstructive urologist Dr. Divya Ajay shares how real patient experiences inspired a first-of-its-kind decision tool that helps people compare diversion options, set realistic expectations and better prepare for life after surgery. From intimacy and travel to recovery, aging and day-to-day living, this conversation offers practical guidance that can help patients feel more informed, more confident and more in control of their...
info_outline
Bladder Removal or Preservation? New Answers Emerge
Bladder Cancer Matters
For patients facing recurrent non-muscle invasive bladder cancer, one of the hardest decisions is whether to or pursue . In this eye-opening episode, leading bladder cancer expert Angela Smith shares the surprising results of the landmark CISTO study—the first major patient-centered research effort to compare these two approaches from the patient's perspective. Discover why some outcomes favored bladder preservation, why others unexpectedly favored radical cystectomy and how these findings are reshaping conversations between patients and their doctors. If you or a loved one are weighing ,...
info_outline
You’re Not Alone: A Guide to BCAN’s Bladder Cancer Support
Bladder Cancer Matters
Feeling overwhelmed after a bladder cancer diagnosis? Wondering where to turn for trusted information, emotional support, or practical guidance? In this episode of Bladder Cancer Matters, host Rick Bangs sits down with BCAN’s Director of Education and Advocacy, Patricia Rios, for an inside look at the many free resources designed to help patients, caregivers and families navigate bladder cancer with more confidence and less fear. From one-on-one peer support and patient summits to clinical trial tools, webinars, caregiver resources, support groups, survivorship planning, and even BCAN’s...
info_outline
Beyond BCG: What Comes Next for Patients
Bladder Cancer Matters
In this episode of , host and survivor Rick Bangs sits down with ImmunityBio’s Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment. They unpack how next-generation immunotherapies like ANKTIVA—paired with innovative approaches to BCG—are reshaping care for patients, especially those with limited options, while also tackling real-world challenges like ongoing BCG shortages. Dr. Reddy breaks down the science in a way that’s accessible, highlighting how activating the body’s own immune system could lead to longer-lasting...
info_outline
What Happens After TURBT Matters More Than You Think
Bladder Cancer Matters
In this episode of , host Rick Bangs sits down with urologic oncologist Dr. Minhaj Siddiqui to break down a critical but often overlooked gap in bladder cancer care—and what it means for patients. They explore how is treated, why a simple step after surgery can dramatically reduce recurrence risk, and the surprising reality that many patients aren’t receiving this guideline-recommended therapy. Dr. Siddiqui shares insights from a groundbreaking national quality improvement initiative aiming to change that, while also offering practical advice patients can use to advocate...
info_outline
A Lifeline for Women Facing Bladder Cancer
Bladder Cancer Matters
In this powerful episode of , a podcast by the Bladder Cancer Advocacy Network, host and survivor Rick Bangs sits down with Vanderbilt nurse Bree Duncan to explore a groundbreaking new role dedicated solely to supporting women with bladder cancer. Created through the vision and generosity of a grateful patient, this female bladder cancer care coordinator position is transforming how women—especially those facing - experience care, offering direct access, emotional support, faster answers, and a steady, compassionate presence during one of the most overwhelming times of their lives. ...
info_outline
What Patients Need to Know About Immunotherapy in 2026
Bladder Cancer Matters
In this episode of , host Rick Bangs speaks with Dr. Josefa Briceno of AstraZeneca about why bladder cancer care may be at a true turning point. From exploring earlier in the disease journey — even around the time of surgery — to strengthening collaboration between urologists and medical oncologists, the conversation highlights how timing, teamwork, and informed shared decision-making are reshaping care. Dr. Briceno explains what this shift means for patients, why education and self-advocacy are essential, and how partnerships between industry and advocacy organizations like BCAN help...
info_outline
Dancing Through Diagnosis: One Educator’s Bladder Cancer Journey
Bladder Cancer Matters
In this powerful episode of Bladder Cancer Matters, Rick Bangs sits down with Mike Vasallo, a high school assistant principal diagnosed with early-onset bladder cancer at 46 who turned fear and uncertainty into purpose. Mike shares his raw, honest journey through diagnosis, treatment and recovery—and how finding community, asking for help and leaning into advocacy changed everything. He also explains how he uses humor, data and even TikTok trends to educate and reach people who might never otherwise learn about bladder cancer. The conversation dives into the emotional toll of cancer, the...
info_outlineBladder cancer survivor Fran Curtis shares her powerful journey on Bladder Cancer Matters, discussing her experience with ADSTILADRIN® (nadofaragene firadenovec-vncg), the impact of early detection, and her advocacy work with BCAN. Diagnosed with non-muscle invasive bladder cancer after subtle urinary changes, Fran highlights the importance of listening to your body, seeking the best care, and finding hope through community support. Released during International Women's History Month, this episode underscores the need for gender equity in healthcare. Tune in to hear Fran’s inspiring story and insights!
IMPORTANT SAFETY INFORMATION
Who should not receive ADSTILADRIN? Do not receive ADSTILADRIN if you have a sensitivity to interferon alfa or any of its components.
What is the most important information I should know about ADSTILADRIN? Individuals who are immunosuppressed or immune-deficient should not prepare, administer, receive, or come into contact with ADSTILADRIN.
What should I tell my healthcare provider? Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of ADSTILADRIN? The most common side effects of ADSTILADRIN include: Urinary discharge, fatigue, bladder spasm, urgency to urinate, and blood in your urine.
These are not all the possible side effects of ADSTILADRIN. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088. You may also contact Ferring Pharmaceuticals at 1-888-FERRING.
What other information should I know about using ADSTILADRIN? For 2 days following treatment, voided urine should be disinfected for 15 minutes with an equal volume of bleach before flushing.
For more important information, call 1-888-337-7464.
Please see full Prescribing Information.